lung function

June 19, 2017June 19, 2017

Australian Pulmonary Fibrosis Registry Offers Real-world Insight Into the Disease

Patients in the Australian Idiopathic Pulmonary Fibrosis Registry who take anti-fibrotic therapies tend to live longer than those who do not, according to an analysis of the records. Another finding ... Read more

June 13, 2017June 13, 2017

Orkambi Improves Lung Function of Children with Cystic Fibrosis, Update of Trial Results Indicates

Cystic Fibrosis, News

Vertex Pharmaceuticals‘ Orkambi significantly improved the lung function of children with cystic fibrosis, compared with a placebo, according to updated Phase 3 clinical trial results. An update of another Phase 3 trial’s ... Read more

May 25, 2017May 25, 2017

Esbriet Subgroup Analyses Suggest Benefits Also in Moderate and Severe IPF

Idiopathic Pulmonary Fibrosis, News

Patients with more severe idiopathic pulmonary fibrosis (IPF) also benefit from Esbriet (pirfenidone) treatment, as do IPF patients with moderate lung function impairment, according to two studies presented at the ... Read more

April 11, 2017April 11, 2017

Researchers Review Performance of Genentech’s Esbriet in Treating Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News

Genentech’s Esbriet (pirfenidone), approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat idiopathic pulmonary fibrosis (IPF), prolongs survival in patients and is generally safe, concludes a review, “Role ... Read more

April 4, 2017April 4, 2017

Tezacaftor-Kalydeco Combo Is Promising CF Treatment, Phase 3 Trials Show

Cystic Fibrosis, News

A combination of tezacaftor and ivacaftor significantly improved lung function in cystic fibrosis (CF) patients 12 years and older who had a F508del mutation, according to two Phase 3 clinical ... Read more

February 2, 2017February 2, 2017

Reduced Infant Lung Function an Indicator of Chronic Asthma in Young Adults, Study Shows

Asthma, News

Reduced lung function in infants points to chronic asthma in young adults, according to a recent study. The findings suggest that asthma may be caused by abnormal lung development and growth ... Read more

January 16, 2017January 16, 2017

Strategies Needed to Improve Adherence to COPD Medications, Study Says

COPD, News

Humana and Boehringer Ingelheim Pharmaceuticals have published a study showing that non-adherence to chronic obstructive pulmonary disease (COPD) medications is linked to non-adherence to medications for other chronic diseases. The ... Read more

January 11, 2017January 11, 2017

Molecule Seen to Be Marker of Sclerosis-linked Lung Disease, Its Severity

Scleroderma

In the majority of patients with systemic sclerosis (SSc), interstitial lung disease (ILD) is the leading cause of death. New research shows that plasma levels of the molecule CXCL4 are ... Read more

December 8, 2016December 8, 2016

Study Links Menopause to Lung Function Decline in Women

News

Menopausal women experience a decline in lung function similar to smoking 20 cigarettes a day for a decade, according to new research from Norway. The study, “Menopause is Associated with ... Read more

October 14, 2016October 14, 2016

Pivotal Clinical Trial of Zephyr Endobronchial Valve for Emphysema Completes Enrollment

News

Pulmonx announced that patient enrollment is complete for its pivotal investigational device exemption (IDE) study of the Zephyr Endobronchial Valve (EBV) for the treatment of severe emphysema. Results from the randomized, multi-center LIBERATE clinical ... Read more